CLINICAL TRIALS PROFILE FOR CEFTAZIDIME SODIUM IN PLASTIC CONTAINER

All Clinical Trials for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00333385 ↗	Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis	Terminated	Baxter Healthcare Corporation	Phase 4	2001-10-01	The aim of this trial was to compare the safety and efficacy of courses of tobramycin and ceftazidime, administered intravenously as either thrice daily short infusions or 24 h continuous infusion, in cystic fibrosis patients with acute exacerbation of chronic pulmonary PA infection. In conventional treatment regimens, ceftazidime is administered in the form of thrice daily short infusions, but pharmacodynamic considerations suggest that continuous infusion could be more effective.
NCT00333385 ↗	Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis	Terminated	GlaxoSmithKline	Phase 4	2001-10-01	The aim of this trial was to compare the safety and efficacy of courses of tobramycin and ceftazidime, administered intravenously as either thrice daily short infusions or 24 h continuous infusion, in cystic fibrosis patients with acute exacerbation of chronic pulmonary PA infection. In conventional treatment regimens, ceftazidime is administered in the form of thrice daily short infusions, but pharmacodynamic considerations suggest that continuous infusion could be more effective.
NCT00333385 ↗	Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis	Terminated	Roche Pharma AG	Phase 4	2001-10-01	The aim of this trial was to compare the safety and efficacy of courses of tobramycin and ceftazidime, administered intravenously as either thrice daily short infusions or 24 h continuous infusion, in cystic fibrosis patients with acute exacerbation of chronic pulmonary PA infection. In conventional treatment regimens, ceftazidime is administered in the form of thrice daily short infusions, but pharmacodynamic considerations suggest that continuous infusion could be more effective.
NCT00333385 ↗	Continuous Versus Short Infusions of Ceftazidime in Cystic Fibrosis	Terminated	Vaincre la Mucoviscidose	Phase 4	2001-10-01	The aim of this trial was to compare the safety and efficacy of courses of tobramycin and ceftazidime, administered intravenously as either thrice daily short infusions or 24 h continuous infusion, in cystic fibrosis patients with acute exacerbation of chronic pulmonary PA infection. In conventional treatment regimens, ceftazidime is administered in the form of thrice daily short infusions, but pharmacodynamic considerations suggest that continuous infusion could be more effective.

Clinical Trial Conditions for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER

Condition Name

Condition Name for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Intervention	Trials
Chronic Appendicitis	1
Cystic Fibrosis	1
Melioidosis	1
Pseudomonas Aeruginosa	1

Condition MeSH

Condition MeSH for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Intervention	Trials
Infections	1
Infection	1
Melioidosis	1
Communicable Diseases	1

Clinical Trial Locations for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER

Trials by Country

Trials by Country for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Location	Trials
China	2
Brazil	1
France	1

Clinical Trial Progress for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER

Clinical Trial Phase

Clinical Trial Phase for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Phase 4	2
Phase 2	2
N/A	1

Clinical Trial Status

Clinical Trial Status for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Clinical Trial Phase	Trials
Enrolling by invitation	1
Not yet recruiting	1
Suspended	1

Clinical Trial Sponsors for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER

Sponsor Name

Sponsor Name for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Sponsor	Trials
GlaxoSmithKline	1
Roche Pharma AG	1
Vaincre la Mucoviscidose	1

Sponsor Type

Sponsor Type for CEFTAZIDIME SODIUM IN PLASTIC CONTAINER
Sponsor	Trials
Other	5
Industry	5